BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calevro A, Cotel MC, Natesan S, Modo M, Vernon AC, Mondelli V. Effects of chronic antipsychotic drug exposure on the expression of Translocator Protein and inflammatory markers in rat adipose tissue. Psychoneuroendocrinology 2018;95:28-33. [PMID: 29793094 DOI: 10.1016/j.psyneuen.2018.05.021] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pariante CM. The year of immunopsychiatry: A special issue that foresaw the future. Psychoneuroendocrinology 2019;103:49-51. [PMID: 30640037 DOI: 10.1016/j.psyneuen.2019.01.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Li H, Peng S, Li S, Liu S, Lv Y, Yang N, Yu L, Deng YH, Zhang Z, Fang M, Huo Y, Chen Y, Sun T, Li W. Chronic olanzapine administration causes metabolic syndrome through inflammatory cytokines in rodent models of insulin resistance. Sci Rep 2019;9:1582. [PMID: 30733507 DOI: 10.1038/s41598-018-36930-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
3 Dinesh AA, Islam J, Khan J, Turkheimer F, Vernon AC. Effects of Antipsychotic Drugs: Cross Talk Between the Nervous and Innate Immune System. CNS Drugs 2020;34:1229-51. [PMID: 32975758 DOI: 10.1007/s40263-020-00765-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
4 Fernandes MS, Barbisan F, Azzolin VF, do Prado-Lima PAS, Teixeira CF, da Cruz Jung IE, Assmann CE, Riffel RT, Duarte MMMF, Aguiar-Ribeiro EM, da Cruz IBM. Lithium is able to minimize olanzapine oxidative-inflammatory induction on macrophage cells. PLoS One 2019;14:e0209223. [PMID: 30695037 DOI: 10.1371/journal.pone.0209223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
5 Ferreira V, Grajales D, Valverde ÁM. Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view. Biochim Biophys Acta Mol Cell Biol Lipids 2020;1865:158534. [PMID: 31672575 DOI: 10.1016/j.bbalip.2019.158534] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ersland KM, Myrmel LS, Fjære E, Berge RK, Madsen L, Steen VM, Skrede S. One-Year Treatment with Olanzapine Depot in Female Rats: Metabolic Effects. Int J Neuropsychopharmacol 2019;22:358-69. [PMID: 30854556 DOI: 10.1093/ijnp/pyz012] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
7 Miron IC, Popescu F, Enăchescu V, Cristea OM, Stoicănescu EC, Amzoiu E, Amzoiu M, Popescu FD. Combination of Olanzapine Pamoate with Melatonin and Metformin: Quantitative Changes in Rat Adipose Tissue. Curr Health Sci J 2019;45:372-82. [PMID: 32110439 DOI: 10.12865/CHSJ.45.04.05] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Corsi-zuelli F, Loureiro CM, Shuhama R, Fachim HA, Menezes PR, Louzada-junior P, Mondelli V, Del-ben CM. Cytokine profile in first-episode psychosis, unaffected siblings and community-based controls: the effects of familial liability and childhood maltreatment. Psychol Med 2020;50:1139-47. [DOI: 10.1017/s0033291719001016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]